© 2020 – 2024 AEA3 WEB | AEAƎ China News

WHO extends coverage of SINOVAC’s COVID-19 vaccine for 3-year-olds

WHO has expanded the use of Chinese manufacturer SINOVAC Biotech’s COVID-19 vaccine for children aged 3-17, making it the first and only vaccine on the WHO’s Emergency Use Listing (EUL) that has been recommended for children aged 3-4.

Related posts

Tianjin opens new container shipping route to Europe


Wang urges region to be wary of disruptive forces


Beijing subway adopts dual temperature mode